Conversion of 7-Carboxy-Cannabidiol (7-COOH-CBD) to 11-Nor-9-Carboxy-Tetrahydrocannabinol (THC-COOH) during Sample Preparation for GC-MS Analysis
The growing use of cannabidiol (CBD) products by the general public is expected to result in an increase in the prevalence of CBD and the CBD metabolites in drug testing laboratories. CBD converts into tetrahydrocannabinol (THC) under acid conditions which could produce false-positive results, but little is known about how the presence of the urinary metabolite of CBD, 7-carboxy-cannabidiol (7-COOH-CBD), would affect urine drug testing for 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH). As the operators of the National Laboratory Certification Program (NLCP), we prepared a set of performance testing samples containing 7-COOH-CBD for cannabinoid testing at the laboratories accredited by the NLCP to investigate if 7-COOH-CBD can produce false-positive results for THC-COOH during immunological screening analysis and if 7-COOH-CBD can be converted to THC-COOH. At concentrations up to 2,500 ng/mL, 7-COOH-CBD was not reactive by immunoassay in any of the four different immunoassay kits used. Additionally, we did not observe any significant conversion of 7-COOH-CBD to THC-COOH in assays used by NLCP-certified laboratories. However, we did see conversion when we requested that selected laboratories retest their samples using derivatization with perfluorinated anhydrides in combination with perfluorinated alcohols or when samples containing 7-COOH-CBD were exposed to acid for an extended time.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: [email protected].
Similar articles
Coulter C, Wagner JR. Coulter C, et al. J Anal Toxicol. 2021 Sep 17;45(8):807-812. doi: 10.1093/jat/bkab074. J Anal Toxicol. 2021. PMID: 34137890
Vikingsson S, Winecker RE, Cone EJ, Kuntz DJ, Dorsey B, Jacques M, Senter M, Flegel RR, Hayes ED. Vikingsson S, et al. J Anal Toxicol. 2022 Oct 14;46(8):866-874. doi: 10.1093/jat/bkac013. J Anal Toxicol. 2022. PMID: 35260906
Kieliba T, Lerch O, Andresen-Streichert H, Rothschild MA, Beike J. Kieliba T, et al. Drug Test Anal. 2019 Feb;11(2):267-278. doi: 10.1002/dta.2490. Epub 2018 Sep 25. Drug Test Anal. 2019. PMID: 30144294
How ZT, Gamal El-Din M. How ZT, et al. Environ Pollut. 2021 Jan 1;268(Pt A):115642. doi: 10.1016/j.envpol.2020.115642. Epub 2020 Sep 14. Environ Pollut. 2021. PMID: 33032096 Free PMC article. Review.
Henson JD, Vitetta L, Hall S. Henson JD, et al. Inflammopharmacology. 2022 Aug;30(4):1167-1178. doi: 10.1007/s10787-022-01020-z. Epub 2022 Jul 7. Inflammopharmacology. 2022. PMID: 35796920 Free PMC article. Review.